PL2123271T3 - Lek do leczenia grypy - Google Patents

Lek do leczenia grypy

Info

Publication number
PL2123271T3
PL2123271T3 PL08721158T PL08721158T PL2123271T3 PL 2123271 T3 PL2123271 T3 PL 2123271T3 PL 08721158 T PL08721158 T PL 08721158T PL 08721158 T PL08721158 T PL 08721158T PL 2123271 T3 PL2123271 T3 PL 2123271T3
Authority
PL
Poland
Prior art keywords
influenza
drug
treatment
prophylactic
therapeutic
Prior art date
Application number
PL08721158T
Other languages
English (en)
Inventor
Makoto Yamashita
Yoshihiro Kawaoka
Original Assignee
Daiichi Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Sankyo Co Ltd filed Critical Daiichi Sankyo Co Ltd
Publication of PL2123271T3 publication Critical patent/PL2123271T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL08721158T 2007-03-07 2008-03-03 Lek do leczenia grypy PL2123271T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2007056872 2007-03-07
PCT/JP2008/053738 WO2008108323A1 (ja) 2007-03-07 2008-03-03 インフルエンザ治療剤
EP08721158A EP2123271B1 (en) 2007-03-07 2008-03-03 Drug for treatment of influenza

Publications (1)

Publication Number Publication Date
PL2123271T3 true PL2123271T3 (pl) 2012-03-30

Family

ID=39738201

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08721158T PL2123271T3 (pl) 2007-03-07 2008-03-03 Lek do leczenia grypy

Country Status (16)

Country Link
US (2) US20100204314A1 (pl)
EP (1) EP2123271B1 (pl)
JP (2) JP5286251B2 (pl)
KR (1) KR101473028B1 (pl)
CN (1) CN101715343B (pl)
AT (1) ATE526960T1 (pl)
CA (1) CA2680415A1 (pl)
CY (1) CY1112201T1 (pl)
DK (1) DK2123271T3 (pl)
ES (1) ES2372996T3 (pl)
HR (1) HRP20110861T1 (pl)
PL (1) PL2123271T3 (pl)
PT (1) PT2123271E (pl)
SI (1) SI2123271T1 (pl)
TW (1) TWI424841B (pl)
WO (1) WO2008108323A1 (pl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7960139B2 (en) 2007-03-23 2011-06-14 Academia Sinica Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
EP2318832B1 (en) 2008-07-15 2013-10-09 Academia Sinica Glycan arrays on ptfe-like aluminum coated glass slides and related methods
US11377485B2 (en) 2009-12-02 2022-07-05 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10087236B2 (en) 2009-12-02 2018-10-02 Academia Sinica Methods for modifying human antibodies by glycan engineering
US10338069B2 (en) 2010-04-12 2019-07-02 Academia Sinica Glycan arrays for high throughput screening of viruses
CN103068378B (zh) * 2010-05-10 2016-07-06 中央研究院 具有抗流感活性的扎那米韦膦酸酯同类物及其制备方法
EP2960237A1 (en) * 2011-12-16 2015-12-30 Daiichi Sankyo Company, Limited Method for producing neuraminic acid derivative
US10130714B2 (en) 2012-04-14 2018-11-20 Academia Sinica Enhanced anti-influenza agents conjugated with anti-inflammatory activity
JP6302909B2 (ja) 2012-08-18 2018-03-28 アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ シアリダーゼの同定および画像化のための細胞透過性プローブ
US10086054B2 (en) 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
WO2014210564A1 (en) 2013-06-27 2014-12-31 Academia Sinica Glycan conjugates and use thereof
CA2923579C (en) 2013-09-06 2023-09-05 Academia Sinica Human inkt cell activation using glycolipids with altered glycosyl groups
US9982041B2 (en) 2014-01-16 2018-05-29 Academia Sinica Compositions and methods for treatment and detection of cancers
US10150818B2 (en) 2014-01-16 2018-12-11 Academia Sinica Compositions and methods for treatment and detection of cancers
CN106415244B (zh) 2014-03-27 2020-04-24 中央研究院 反应性标记化合物及其用途
US20150344585A1 (en) 2014-05-27 2015-12-03 Academia Sinica Anti-cd20 glycoantibodies and uses thereof
US10118969B2 (en) 2014-05-27 2018-11-06 Academia Sinica Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
EP3904388A1 (en) 2014-05-27 2021-11-03 Academia Sinica Fucosidase from bacteroides and methods using the same
CN106661099A (zh) 2014-05-27 2017-05-10 中央研究院 抗her2醣抗体及其用途
EP3154582A4 (en) 2014-05-28 2018-01-10 Academia Sinica Anti-tnf-alpha glycoantibodies and uses thereof
EP3191500A4 (en) 2014-09-08 2018-04-11 Academia Sinica HUMAN iNKT CELL ACTIVATION USING GLYCOLIPIDS
US9975965B2 (en) 2015-01-16 2018-05-22 Academia Sinica Compositions and methods for treatment and detection of cancers
US10495645B2 (en) 2015-01-16 2019-12-03 Academia Sinica Cancer markers and methods of use thereof
CA2972072A1 (en) 2015-01-24 2016-07-28 Academia Sinica Novel glycan conjugates and methods of use thereof
KR20180114210A (ko) 2016-03-08 2018-10-17 아카데미아 시니카 N-글리칸의 모듈 합성 방법 및 그의 어레이
US10538592B2 (en) 2016-08-22 2020-01-21 Cho Pharma, Inc. Antibodies, binding fragments, and methods of use
WO2019073298A1 (en) * 2017-10-11 2019-04-18 Lifescience As N-acetylneuraminic acid compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6451766B1 (en) * 1996-07-22 2002-09-17 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP3209946B2 (ja) * 1996-07-22 2001-09-17 三共株式会社 ノイラミン酸誘導体
DE69709795T2 (de) * 1996-07-22 2002-09-26 Sankyo Co., Ltd. Neuraminsäuredervate, ihre Herstellung und medizinische Verwendung
US6340702B1 (en) * 1996-07-22 2002-01-22 Sankyo Company, Limited Neuraminic acid derivatives, their preparation and their medical use
JP4151800B2 (ja) 1996-08-13 2008-09-17 第一三共株式会社 ノイラミン酸化合物
JP3920041B2 (ja) 2000-04-25 2007-05-30 三共株式会社 ノイラミン酸化合物の水和物及び結晶
TWI291462B (en) * 2000-04-25 2007-12-21 Daiichi Sankyo Co Ltd Hydrate crystal of neuraminic acid compound
DE602006003600D1 (de) 2005-08-22 2008-12-24 Delphi Tech Inc Nockenwellenversteller zur Einstellung der Phase zwischen einer Nockenwelle und einem Antriebsrad

Also Published As

Publication number Publication date
HRP20110861T1 (hr) 2011-12-31
JP5286251B2 (ja) 2013-09-11
TW200848018A (en) 2008-12-16
SI2123271T1 (sl) 2012-05-31
JP2013139483A (ja) 2013-07-18
KR20090129414A (ko) 2009-12-16
JP6012076B2 (ja) 2016-10-25
CA2680415A1 (en) 2008-09-12
EP2123271A1 (en) 2009-11-25
WO2008108323A1 (ja) 2008-09-12
JPWO2008108323A1 (ja) 2010-06-17
CN101715343B (zh) 2012-09-26
ES2372996T3 (es) 2012-01-30
TWI424841B (zh) 2014-02-01
US20100204314A1 (en) 2010-08-12
PT2123271E (pt) 2011-12-20
ATE526960T1 (de) 2011-10-15
EP2123271B1 (en) 2011-10-05
KR101473028B1 (ko) 2014-12-15
DK2123271T3 (da) 2012-01-23
CN101715343A (zh) 2010-05-26
EP2123271A4 (en) 2010-03-17
US20140018418A1 (en) 2014-01-16
HK1137142A1 (en) 2010-07-23
CY1112201T1 (el) 2015-12-09

Similar Documents

Publication Publication Date Title
PL2123271T3 (pl) Lek do leczenia grypy
IL204621A (en) Amino Acid Derivatives - γ - In bicycles preparations containing them and their uses
TW200728307A (en) Novel spirochromanone derivatives
SG171617A1 (en) Therapeutic compounds
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TW200833675A (en) Nicotinamide derivatives
MX2010004232A (es) Compuesto de indolina de pirimidilo.
WO2007084728A3 (en) 2-imino-benzimidazoles
TW200621737A (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009012125A (es) Compuestos terapeuticos.
DK1694318T3 (da) (S)-2-N-propylamino-5-hydroxytetralin som D3-agonistisk terapeutikum
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
MX2011011776A (es) Nuevos profarmacos de triptolite.
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
WO2009051223A1 (ja) 白内障処置のための医薬組成物
MY158069A (en) Tricyclic compound and pharmaceutical use thereof
MY138466A (en) Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
MX2011012068A (es) Nucleosidos 2'-fluoro arabino y su utilizaicon.
IL201795A0 (en) Stereoisomers propofol therapeutic compounds
MY139228A (en) Imidazolinylmethyl aralkylsulfonamides
MX2010001303A (es) Compuestos terapeuticos.
TN2012000093A1 (en) Therapeutic agent for anxiety disorders
MX2010001304A (es) Compuestos terapeuticos.
IL172290A0 (en) Use of 2-amino-1-3-propanediol derivatives for the manufacture of a medicament for the treatment of various types of pain
MX2009012349A (es) Compuestos de ((fenil)imidazolil)metilheteroarilo.